QA: Esperion Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001434868_2024_Esperion_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001434868, Esperion Therapeutics Inc

  xvar xval
0 AssetsCurrent 201,065,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 4,731,000
4 LiabilitiesCurrent 156,224,000
5 LiabilitiesNoncurrent 3,020,000
6 remainder_Liabilities 501,546,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 144,576,005
9 ResearchAndDevelopmentExpense 63,065,375
10 remainder_Expenses 172,429,917
11 remainder_Revenues 116,548,151
12 remainder_NetIncome 3,832,480
13 remainder_ComprehensiveNetIncome 15,187
  yvar yval
0 Assets 205,796,000
1 Liabilities 660,790,000
2 Expenses 380,071,297
3 Revenues 116,548,151
4 StockholdersEquity -454,994,000
5 NetIncome -259,690,666
6 ComprehensiveNetIncome -259,683,072
7 BaseVar 683,526,558
8 EconomicCapitalRatiobeforeLimitedLiability -2.89
9 EconomicCapitalRatio 0.724

Edgar->Model Mapping

Feature Distribution

Change over Time